Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Open in API
Filings indexed 270 across all filing types
Latest filing 2026-01-09 Regulatory Filings
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Dopuszczenie i warunkowe wprowadzenie akcji zwykłych na okaziciela serii O Spółki do obrotu giełdowego na głównym rynku GPW - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a short announcement from Bioceltix S.A. regarding the decision of the Warsaw Stock Exchange (GPW) to admit and introduce new series O shares to trading. This is a notification of a capital change/share issuance event rather than a full report or a simple publication notice. Given the specific nature of share issuance and listing, it fits the 'Share Issue/Capital Change' category.
2026-01-09 Polish
Warunkowa rejestracja akcji zwykłych Spółki na okaziciela serii O w depozycie papierów wartościowych prowadzonym przez KDPW S.A. - Content (PL)
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement from Bioceltix S.A. regarding the registration of new shares (Series O) with the Central Securities Depository of Poland (KDPW). It details the procedural steps for share registration and admission to trading on the Warsaw Stock Exchange. Since this relates to the issuance and registration of new shares, it falls under the category of share issues and capital changes.
2026-01-07 Polish
Terminy publikacji raportów okresowych w 2026 roku - Content (PL)
Report Publication Announcement Classification · 1% confidence The document is a short announcement from Bioceltix S.A. detailing the specific calendar dates for the publication of their periodic reports (annual, quarterly, and semi-annual) for the year 2026. It does not contain the actual financial reports, but rather serves as a notification of the reporting schedule. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement.
2026-01-05 Polish
Otrzymanie raportu z inspekcji Głównego Inspektora Farmaceutycznego potwierdzającego zgodność z Dobrą Praktyką Wytwarzania - Content (PL)
Audit Report / Information Classification · 1% confidence The document is a regulatory announcement from Bioceltix S.A. regarding the receipt of a final inspection report from the Chief Pharmaceutical Inspector (GIF) concerning Good Manufacturing Practice (GMP) compliance. It details the findings of the inspection and the company's obligation to respond. Since this is a formal regulatory disclosure regarding a specific audit/inspection outcome rather than a financial report, a management change, or a simple publication notice, it falls under the category of Regulatory Filings (RNS). FY 2025
2025-12-23 Polish
Tekst jednolity statutu Spółki
Audit Report / Information Classification · 1% confidence The document is a 'Tekst Jednolity Statutu' (Uniform Text of the Articles of Association) for Bioceltix S.A. This document outlines the company's internal governance rules, business scope, and capital structure. In the context of corporate filings, the Articles of Association are a fundamental governance document that defines the company's legal framework. Since it does not fit into specific financial reporting categories like 10-K or IR, and is not a meeting announcement or proxy, it falls under the 'Governance Information' category, which covers internal rules and board/corporate structure.
2025-12-19 Polish
Rejestracja podwyższenia kapitału zakładowego i zmian statutu Spółki w rejestrze przedsiębiorców Krajowego Rejestru Sądowego - Content (PL)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from Bioceltix S.A. announcing the registration of a capital increase and changes to the company's articles of association following a share issuance (Series O). It details the new share structure and total voting rights. While it mentions the issuance of shares, it is primarily a formal notification of a capital change and statutory amendment, which fits the 'Share Issue/Capital Change' category.
2025-12-19 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.